Your browser doesn't support javascript.
The shortcomings of tocilizumab in COVID-19.
Tirupathi, Raghavendra; Bharathidasan, Kavya; Areti, Swetha; Kaur, Jagdeep; Salim, Sohail; Al-Tawfiq, Jaffar A.
  • Tirupathi R; Department of Medicine, Penn State University School of Medicine, Hershey, PA, USA; Keystone Infectious Diseases/HIV, Keystone Health, Chambersburg, PA, USA; Department of Medicine, Wellspan Chambersburg and Waynesboro Hospitals, Chambersburg, PA, USA.
  • Bharathidasan K; Vydehi Institute of Medical Sciences and Research Center, Bangalore, India.
  • Areti S; Department of Medicine, Wellspan Chambersburg and Waynesboro Hospitals, Chambersburg, PA, USA.
  • Kaur J; Department of Psychiatry, Keystone Health, Chambersburg, PA, USA.
  • Salim S; Department of Nephrology, University of Mississippi Medical Center, Jackson, MS, USA.
  • Al-Tawfiq JA; Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Balti
Infez Med ; 28(4): 465-468, 2020 Dec 01.
Article in English | MEDLINE | ID: covidwho-950599
Search on Google
Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Antibodies, Monoclonal, Humanized / Cytokine Release Syndrome / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Infez Med Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: United States

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Antibodies, Monoclonal, Humanized / Cytokine Release Syndrome / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Infez Med Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: United States